Evidence map›Paper›PMID 41204969›Full record

ArticleActa neuropathologica2025

PolyGR-containing aggregates link with pathology and clinical features of Alzheimer's disease.

Huong T Phuong, Rodrigo F Tomas, Cemal Akmese, Ana Mijares, Isabella M Gerstin, Shu Guo, Logan R Bell, Ross Ellwood, Svitlana Yegorova, Stefani K Ng and 11 more

Abstract read
In one paragraph

Article in Acta neuropathologica, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Huong T Phuong *Center for NeuroGenetics, College of Medicine, University of Florida, Gainesville, USA.
Rodrigo F Tomas *Center for NeuroGenetics, College of Medicine, University of Florida, Gainesville, USA.
Cemal AkmeseCenter for NeuroGenetics, College of Medicine, University of Florida, Gainesville, USA.
Ana MijaresCenter for NeuroGenetics, College of Medicine, University of Florida, Gainesville, USA.
Isabella M GerstinCenter for NeuroGenetics, College of Medicine, University of Florida, Gainesville, USA.
Shu GuoCenter for NeuroGenetics, College of Medicine, University of Florida, Gainesville, USA.
Logan R BellCenter for NeuroGenetics, College of Medicine, University of Florida, Gainesville, USA.
Ross EllwoodCenter for NeuroGenetics, College of Medicine, University of Florida, Gainesville, USA.
Svitlana YegorovaCenter for NeuroGenetics, College of Medicine, University of Florida, Gainesville, USA.
Stefani K NgCenter for NeuroGenetics, College of Medicine, University of Florida, Gainesville, USA.
Grace MasseyCenter for NeuroGenetics, College of Medicine, University of Florida, Gainesville, USA.
Jennifer PhillipsDepartment of Pathology, Immunology and Laboratory Medicine, College of Medicine, University of Florida, Gainesville, USA.
Alexandra MelloniMassGeneral Institute for Neurodegenerative Disease, Massachusetts General Hospital, Boston, USA.
Olga PletnikovaDepartment of Pathology, The Johns Hopkins University School of Medicine, Baltimore, USA.
XiangYang LouDepartment of Biostatistics, University of Florida, Gainesville, USA.
H Brent ClarkDepartment of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, USA.
Juan C TroncosoDepartment of Pathology, The Johns Hopkins University School of Medicine, Baltimore, USA.
Bradley T HymanMassGeneral Institute for Neurodegenerative Disease, Massachusetts General Hospital, Boston, USA.
Stefan ProkopDepartment of Pathology, Immunology and Laboratory Medicine, College of Medicine, University of Florida, Gainesville, USA.
Laura P W RanumCenter for NeuroGenetics, College of Medicine, University of Florida, Gainesville, USA.
Lien NguyenCenter for NeuroGenetics, College of Medicine, University of Florida, Gainesville, USA. lien.nguyen@ufl.edu.

Funding

Research Education ComponentP30AG062421 · NIA · MASSACHUSETTS GENERAL HOSPITAL · PI Teresa Gomez-Isla · 2019 to 2026
$36.5M
Research Education ComponentP30AG066507 · NIA · JOHNS HOPKINS UNIVERSITY · PI Corinne Pettigrew · 2020 to 2026
$29.3M
Social Determinants of Health, Race/Ethnicity, and White Matter HyperintensitiesP30AG066506 · NIA · UNIVERSITY OF FLORIDA · PI Ranjan Duara, DAVID LOEWENSTEIN · 2020 to 2026
$25.6M
University of Florida - Mt. Sinai Medical Center AD Research CenterP50AG047266 · NIA · UNIVERSITY OF FLORIDA · PI FEBO, MARCELO · 2015 to 2019
$7.3M
Molecular effects of metformin, PKR and TBI on C9orf72 ALS/FTDRF1NS098819 · NINDS · UNIVERSITY OF FLORIDA · PI RANUM, LAURA P.W, ZU, TAO · 2022 to 2022
$2.2M
Novel repeat associated non-AUG (RAN) proteins in sALS, sFTD and SBMA: shared pathological features and unifying therapeutic opportunitiesRF1NS126536 · NINDS · UNIVERSITY OF FLORIDA · PI NGUYEN, LIEN, RANUM, LAURA P.W · 2022 to 2022
$1.9M
Studying roles of CASP8 SVA GGGAGA repeat expansions in Alzheimer's diseaseR01AG093746 · NIA · UNIVERSITY OF FLORIDA · PI Lien Nguyen · 2025 to 2026
$1.0M
Identifying and understanding the role of repeat RNAs and RAN proteins in Alzheimer's diseaseR00AG065511 · NIA · UNIVERSITY OF FLORIDA · PI NGUYEN, LIEN · 2023 to 2025
$740k
Identifying and understanding the role of repeat RNAs and RAN proteins in Alzheimer's diseaseK99AG065511 · NIA · UNIVERSITY OF FLORIDA · PI NGUYEN, LIEN · 2020 to 2021
$153k
NIA NIH HHS K99 AG065511NIA NIH HHS P30 AG062421NIA NIH HHS P30 AG066506NIA NIH HHS P30 AG066507NIA NIH HHS P50 AG047266NIA NIH HHS R00 AG065511NIA NIH HHS R01 AG093746NINDS NIH HHS RF1 NS098819NINDS NIH HHS RF1 NS126536
6 · The paper itself

Abstract

Alzheimer's disease is the most common form of dementia; however, its molecular mechanisms are not fully understood. We recently identified polymeric glycine-arginine-containing (polyGR+) aggregates as a novel type of proteinopathy in AD autopsy brains. Here, we performed a comprehensive analysis to study if polyGR+ aggregates are associated with AD neuropathological changes (ADNC) and clinical features of AD cases. We show polyGR+ aggregates are detected in ~ 60% of AD postmortem brains from three AD cohorts but not age-similar controls or disease controls with primary age-related tauopathy (PART). A subtype of polyGR+ aggregates with a clustered-punctate morphology that is positive for the markers of dystrophic neurites is associated with earlier onset and shortened survival in AD cases. Increased levels of Aβ plaques and phosphorylated tau (pTau) tangles are detected in the hippocampus of AD autopsy brains with high levels of polyGR+ aggregates compared to AD autopsy brains with minimal polyGR+ staining. In addition to ADNC, a subset of polyGR+ aggregates coexists with limbic-predominant age-related TDP-43 encephalopathy neuropathological changes (LATE-NC) or Lewy body pathology (LBP). Hippocampal polyGR+ aggregate levels are ~ 3.8- and ~ 3.71-fold higher in late-onset AD cases who experienced stroke or high blood pressure, respectively. In SH-SY5Y cells, hydrogen peroxide treatment which mimics oxidative stress leads to increased levels of polyGR+ proteins produced by the CASP8 GGGAGA repeat expansion, which was recently shown to associate with increased AD risk. In addition, we show the accumulation of pTau induced by CASP8 polyGR+ protein aggregates is elevated upon hydrogen peroxide treatment. In summary, our results demonstrate polyGR+ aggregates are a frequent and understudied type of proteinopathy in AD autopsy brains and that polyGR proteinopathy is associated with ADNC.

Indexed as

Alzheimer DiseaseBrainProtein Aggregation, PathologicalAgedAged, 80 and overAmyloid beta-PeptidesFemaleHumansMaleMiddle AgedNeurofibrillary TanglesPlaque, AmyloidProtein Aggregatestau ProteinsAmyloid beta-PeptidesProtein Aggregatestau ProteinsAD non-genetic factorsAβ plaquesPolymeric glycine–arginineProtein aggregatespTauRepeat expansion variants

Identifiers

PMID41204969
PMCPMC12598690

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.